Dr. Reddy's Laboratories Limited (RDY) NYSE

14.05

+0.025(+0.18%)

Updated at November 19 04:00PM

Currency In USD

Valuation

Market Cap940.26B
Enterprise Value972.37B
P/E Ratio17.8
PEG Ratio5.65
Price/Sales Ratio3.04
Price/Book Ratio2.91
Enterprise/Revenue3.18
Enterprise/EBITDA12.02

Fiscal Year

Fiscal YearMarch 31, 2025
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.17
Operating Margin0.21

Management Effectiveness

Return On Assets0.11
Return On Equity0.17

Income Statement

Revenue325.54B
Revenue/Share409.95
Gross Profit190.43B
EBITDA96.67B
Net Income56.54B
Diluted EPS67.77

Balance Sheet

Total Cash69.81B
Total Cash/Share83.64
Total Debt58.54B
Total Debt/Equity0.16
Current Ratio1.85
Book Value Per Share433.83

Price History

52-Week Change-2.16
52-Week High16.17
52-Week Low12.26
Moving Average 50 Days14.18
Moving Average 200 Days14.08

Statistics

Average Volume1.02M
Shares Outstanding832.48M
% Held by Institutions12.84

Dividend And Splits

Trailing Annual Dividend Rate8
Trailing Annual Dividend Yield0.64
Payout Ratio0.11
Last Split Factor5:1
Last Split DateNovember 05, 2024